Testosterone for Women: What It Actually Treats — and What It Doesn't

Testosterone is having a moment in women’s health. It shows up in podcasts, in influencer “hormone optimization” reels, and in clinic ads promising more energy, a leaner body, sharper focus, and a better mood. Some of that enthusiasm is warranted. A lot of it gets ahead of the evidence.

Here is the honest version, the one we give our own patients: testosterone is a real, useful therapy for women — for one specific thing. For most of the other claims, the science isn’t there yet. And in the United States, there is still no FDA-approved testosterone product made for women, which shapes everything about how it should be prescribed.

If you’ve been told testosterone will fix your fatigue, melt fat, or rebuild your motivation, this article is the conversation worth having before you start.

What testosterone is proven to do in women: improve sexual desire in postmenopausal women with HSDD (hypoactive sexual desire disorder). That is the only indication backed by the 2019 Global Consensus Statement endorsed by The Menopause Society, the Endocrine Society, and others.

What it’s not proven to do: reliably improve fatigue, mood, cognition, bone density, or body composition. The consensus statement reviewed the evidence and didn’t support prescribing for those purposes.

How it should be given: a transdermal cream or gel, dosed to keep blood levels in the normal premenopausal range. Pellets, injections, and oral testosterone are advised against because they tend to push levels too high.

The FDA gap: there’s no FDA-approved testosterone product for women in the US. Clinicians prescribe off-label using a small fraction of a male product or a compounded preparation.

Testosterone is often filed under “the male hormone,” but women produce it throughout their lives — in the ovaries and adrenal glands — and it matters for sexual desire, mood, and tissue health. Levels decline gradually with age, beginning well before menopause. By the time many women reach their late 40s and 50s, circulating testosterone is a fraction of what it was at 25.

That decline is normal. The clinical question is not “are your levels lower than they were at 25” — for almost everyone, they are — but “are you having a specific symptom that testosterone has been shown to improve.” That distinction is the whole ballgame, and it’s where careful clinics and hype-driven ones part ways.

The strongest evidence — and the only indication with broad international agreement — is for hypoactive sexual desire disorder (HSDD) in postmenopausal women. HSDD is persistent, distressing low sexual desire that isn’t explained by a relationship problem, a medication, depression, or another medical cause.

In 2019, a panel representing roughly a dozen major medical societies — including The Menopause Society, the Endocrine Society, the International Menopause Society, and the International Society for the Study of Women’s Sexual Health — published a Global Consensus Position Statement on testosterone therapy for women. Its central conclusion was clear: in postmenopausal women with HSDD, testosterone therapy, dosed to restore premenopausal physiologic levels, produces a moderate but real improvement in sexual desire, arousal, and the number of satisfying sexual events.

That same statement was just as clear about the flip side, which we’ll get to next.

The Global Consensus Statement reviewed the evidence for using testosterone to treat fatigue, low mood, cognitive symptoms, bone density, muscle mass, and general wellbeing in women — and concluded the data don’t support prescribing it for any of those purposes. Not because testosterone was proven useless for them, but because the studies are too limited or too inconsistent to recommend it.

This is the part the marketing skips. “Testosterone for energy and weight loss” is one of the most common pitches in the wellness space, and it is precisely the use the global evidence does not back. Improved sexual desire is, to date, the only proven benefit of testosterone therapy in women. If a clinic is selling testosterone primarily as a fatigue or body-composition treatment, they are ahead of the science.

Despite decades of use, there is no testosterone product approved by the FDA for women in the United States. Australia approved a female testosterone cream (Androfeme) in 2020, and it remains the only country to have done so. Everywhere else, including the US, treating women means prescribing off-label.

In practice, that means one of two things: a clinician uses a small, measured fraction of an FDA-approved male testosterone product, or a compounding pharmacy prepares a custom dose. Both are legal and both are common — but the absence of an approved female product is exactly why dosing, formulation, and monitoring have to be done carefully rather than casually.

There is movement on this front. In 2025 the FDA issued guidance on a development pathway for a female-specific testosterone formulation, the clearest signal in years that an approved product for women may eventually reach the US market. For now, though, responsible prescribing happens in the off-label space, and how it’s done is what separates good care from bad.

The Global Consensus Statement is specific about formulation, because the route of delivery is where a lot of harm happens.

Transdermal is preferred. A cream or gel applied to the skin, dosed to keep blood levels in the normal premenopausal range, is the form supported by the evidence. The goal is restoration, not elevation: bringing testosterone back to a healthy young-adult level, not pushing it past it.

Pellets and injections are advised against. Both tend to deliver supraphysiologic levels — more testosterone than a premenopausal woman would ever naturally make — which is where androgenic side effects come from. The consensus statement specifically recommends against testosterone pellets and injections in women for this reason, despite how heavily pellets in particular are marketed.

Oral testosterone is also advised against, because swallowed testosterone passes through the liver and can adversely affect cholesterol.

When testosterone is kept in the physiologic range, side effects are uncommon. When levels run too high — usually from pellets, injections, or unmonitored dosing — women can experience acne, unwanted hair growth, scalp hair thinning, and, rarely, voice changes that may not fully reverse. Almost all of that is a dosing-and-monitoring problem, not an inherent property of the hormone.

Testosterone therapy is worth a conversation if you are postmenopausal, are experiencing distressing low sexual desire, and other contributors — relationship factors, antidepressants or other medications, thyroid issues, depression, pain with sex, or untreated estrogen-related vaginal symptoms — have been considered first. Often, addressing those other factors is what actually helps, and testosterone is one piece rather than the answer.

It’s a poor fit, or needs real caution, if your main complaint is fatigue, weight, or mood without a desire concern; if you’re looking for “optimization” rather than treatment of a symptom; or if you have certain hormone-sensitive conditions that warrant individual review. Premenopausal use is far less studied, and the consensus evidence centers on postmenopausal women.

Candidacy is genuinely individual. Personal and family history, current medications, and your own goals all factor in — which is why this is a clinician conversation, not a self-diagnosis.

Done well, testosterone therapy for women involves a baseline blood test, a clear symptom you’re actually treating, a physiologic transdermal dose, and follow-up labs to confirm your level landed in the normal range rather than above it. It’s reviewed periodically, and it’s stopped if it isn’t helping. It is not a lifelong commitment you make on day one, and it is not a shortcut around the rest of your health.

If you’ve been curious about testosterone — or have been pitched it as a cure-all and want a straight answer — that’s exactly the kind of conversation we have at Naya Wellness. Carolyn Pampalone, MSN, FNP-BC, has spent nearly two decades in women’s health and hormone care and can help you sort out whether testosterone fits your situation, what the evidence does and doesn’t promise, and how it would be monitored if you moved forward. You can talk it through at our Chatsworth or Santa Barbara clinics, or by telehealth across California.

Two California locations and statewide telehealth — click a card to view details, or call to schedule a consult.